00000nam 2200000zi 4500 9.891862 CaOODSP 20250218133627 m o d f cr cn||||||||| 200928e202010 onca ob f000 0 eng d 9780660361062 CaOODSP eng rda CaOODSP n-cn--- HP40-277/2020E-PDF Recommendations on the duration of the post-vaccination observation period for influenza vaccination during the COVID-19 pandemic. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, October 2020. ©2020 1 online resource (40 pages) : colour illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Recommandations sur la durée de la période d'observation post-vaccinale pour la vaccination antigrippale pendant la pandémie de COVID-19. At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 200209." Issued also in HTML format. Includes bibliographical references (pages 38-40). Influenza Vaccination Canada. Influenza Vaccination Complications Canada. COVID-19 Pandemic, 2020-2023 Canada. COVID-19 (Disease) Canada Prevention. Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. Recommandations sur la durée de la période d'observation post-vaccinale pour la vaccination antigrippale pendant la pandémie de COVID-19. (CaOODSP)9.891866 PDF 2.45 MB https://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-277-2020-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-duration-observation-period-post-influenza-vaccination-during-covid-19-pandemic.html